Has Z Lorenc received payments from drug or device companies?

Yes. Drug and device makers reported $224,548 in general payments to Z Lorenc across 137 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Z Lorenc did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Z Lorenc come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Z Lorenc

Plastic Surgery · New York, NYNPI 1417000845

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $182,865 of the $224,548 with a category attached, or 81.4%. 9 manufacturers reported payments, led by Merz North America, Inc. at 52.0% of the total. 2025 is the largest year on record at $91,397, 5.9 times the $15,571 reported in 2019. Among plastic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$224,548in general payments, 2019–2025

Across 137 payments — averaging $1639.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merz North America, Inc.$117K
Galderma Laboratories, L.p.$52K
IBSA Institut Biochimique SA$20K
Krystal Biotech Inc$16K
AbbVie$15K
Ipsen Innovation$4K
plus $1K from 3 others

$506,034in research payments, 2019–2025

Across 21 payments — averaging $24,097 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Merz North America, Inc.$334K
Galderma Laboratories, L.p.$173K

What the payments were for

Consulting fees$182,86581%
Grants$10,0004%
Travel & lodging$28,03212%
Food & beverage$3,6502%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merz North America, Inc.	64	$116,711
Galderma Laboratories, L.p.	31	$52,274
IBSA Institut Biochimique SA	2	$20,000
Krystal Biotech Inc	4	$16,307
AbbVie(2 entities)	30	$14,651
Ipsen Innovation	2	$3,515
Endo Pharmaceuticals Inc.	1	$940
Solta Medical, A Division Of Bausch Health US, LLC	2	$111
Revance Therapeutics, Inc.	1	$39

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XEOMIN$89,911
DYSPORT$3,515
ASCLERA$144

How this compares

$224,548 in reported general payments places this provider in the 95th percentile of 363 plastic surgery providers in New York.

See all plastic surgery providers in New York →

Other plastic surgery in New York

Sachin ShridharaniNew York$1.1M
Scot GlasbergNew York$959K
Nolan KarpNew York$900K
Sydney ColemanNew York$729K
David RapaportNew York$578K
Richard SwiftNew York$487K
Michael KaneNew York$250K
Joseph DayanNew York$123K
Anna AvalianiNew York$93K
Nicholas VendemiaNew York$86K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →